-Frank Mccormick Researcher Activity Profile

Research Author Detailed Information 

Frank Mccormick Publication Rate By Year

Frank Mccormick has published 6 paper(s) in 2004, 3 paper(s) in 2005, 4 paper(s) in 2006, 5 paper(s) in 2007, 8 paper(s) in 2008, for a total of 26 research publications in total.

Frank F Mccormick Author Information

LAST NAME: mccormick

FIRST NAME: frank

INITIALS: F

AFFILIATION:

Papers

Frank Mccormick's Publication Record

1. Characterization of interactions between ras family GTPases and their effectors. Year Published: 2006
2. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Year Published: 2006
Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94270, USA. rmneve@lbl.gov
3. Activation of p53 by Dishevelled independent of Wnt or planar polarity pathways. Year Published: 2007
UCSF Comprehensive Cancer Center, Cancer Research Institute, 2340 Sutter Street, San Francisco, CA, 94115, USA, mccormick@cc.ucsf.edu.
4. Oncolytic adenoviruses as antiglioma agents. Year Published: 2006
Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Box 316, Houston, TX 77030, USA.
5. Mutation Analysis of BRAF, MEK1 and MEK2 in 15 Ovarian Cancer Cell Lines: Implications for Therapy. Year Published: 2007
Comprehensive Cancer Center and Cancer Research Institute, University of California at San Francisco, San Francisco, California, United States of America.
6. Critical role for arginine methylation in adenovirus-infected cells. Year Published: 2007
UCSF Comprehensive Cancer Center, 2340 Sutter St., San Francisco, CA 94115, USA.
7. Critical role for arginine methylation in adenovirus-infected cells. Year Published: 2007
UCSF Comprehensive Cancer Center, 2340 Sutter St., San Francisco, CA 94115, USA.
8. Inhibition of Wnt-1 signaling induces apoptosis in beta-catenin-deficient mesothelioma cells. Year Published: 2004
Thoracic Oncology Laboratory, Department of Surgery, Comprehensive Cancer Center, University of California, San Francisco, California 94115, USA.
9. Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Year Published: 2004
Thoracic Oncology Laboratory, Department of Surgery, Comprehensive Cancer Center, University of California-San Francisco, 1600 Divisadero Street, San Francisco, CA 94115, USA.
10. An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth. Year Published: 2004
Thoracic Oncology Laboratory, Department of Surgery, Comprehensive Cancer Center, University of California-San Francisco, 1600 Divisadero Street, San Francisco, CA 94143-1674, USA.
11. Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells. Year Published: 2004
Thoracic Oncology Laboratory, Department of Surgery, Comprehensive Cancer Center, University of California, San Francisco, CA 94115, USA.
12. Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma. Year Published: 2004
Thoracic Oncology Laboratory, Department of Surgery, Comprehensive Cancer Center, University of California, San Francisco, CA 94115, USA.
13. Cloning and characterization of the promoter of human Wnt inhibitory factor-1. Year Published: 2004
Thoracic Oncology Laboratory, Department of Surgery, Comprehensive Cancer Center University of California, San Francisco, CA 94115, USA.
14. Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in beta-catenin-deficient human mesothelioma cells. Year Published: 2005
Thoracic Oncology Laboratory, Department of Surgery, Comprehensive Cancer Center, University of California-San Francisco, 1600 Divisadero Street, San Francisco, CA 94115, USA.
15. Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations. Year Published: 2005
Thoracic Oncology Laboratory, Department of Surgery, Comprehensive Cancer Center, University of California, 1600 Divisadero St, C322C, Box 1674, San Francisco, CA 94115, USA.
16. Inhibition of Wnt16 in human acute lymphoblastoid leukemia cells containing the t(1;19) translocation induces apoptosis. Year Published: 2005
UCSF Comprehensive Cancer Center, San Francisco, CA 94115, USA.
17. Wnt-1 signal as a potential cancer therapeutic target. Year Published: 2006
Thoracic Oncology Laboratory, Department of Surgery, Comprehensive Cancer Center, University of California, San Francisco, California 94115, USA.
18. Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and RAF inhibition: implications for therapeutic options. Year Published: 2008
19. Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and RAF inhibition: implications for therapeutic options. Year Published: 2008
Department of Pathology, School of Medicine, University of California, San Francisco, CA 94143-0128, USA.
20. Success and failure on the ras pathway. Year Published: 2008
21. Skp2 Suppresses p53-Dependent Apoptosis by Inhibiting p300. Year Published: 2008
Cancer Research Institute and Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94115, USA; Kasai R&D, Daiichi Sankyo Pharmaceutical Co., Ltd, Tokyo 134-8630, Japan.
22. An analysis of capsular area in patients with anterior, posterior, and multidirectional shoulder instability. Year Published: 2008
Department of Orthopaedic Surgery, Division of Sports Surgery, Naval Medical Center San Diego, San Diego, California 92134-1112, USA.
23. Activation of p53 by Dishevelled independent of Wnt or planar polarity pathways. Year Published: 2007
UCSF Comprehensive Cancer Center, Cancer Research Institute, 2340 Sutter Street, San Francisco, CA 94115, USA.
24. Success and failure on the ras pathway. Year Published: 2008
UCSF Comprehensive Cancer Center, USA. mccormick@cc.ucsf.edu
25. Skp2 suppresses p53-dependent apoptosis by inhibiting p300. Year Published: 2008
Cancer Research Institute and Comprehensive Cancer Center, University of California-San Francisco, San Francisco, CA 94115, USA.
26. Success and failure on the ras pathway. Year Published: 2008
UCSF Comprehensive Cancer Center, USA. mccormick@cc.ucsf.edu